Vaxcyte, Inc. (PCVX)
Market Closed
17 Jul, 20:00
$
56. 20
+0.16
+0.2855%
$
8.41B Market Cap
- P/E Ratio
- Div Yield
1.13M Volume
-3.49 Eps
$ 56.04
Previous Close 
Want to track PCVX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vaxcyte, Inc. (PCVX) Statistics
Valuation metrics
Market Cap 8.41B
Enterprise value 7.97B
Trailing P/E (ttm) -8.16
Forward P/E -8.31
PEG ratio 0.18
Price/Sales (ttm) -
Price/Book (mrq) 2.62
Enterprise Value/Revenue -
Enterprise Value/EBITDA -8.66
Overview
Shares outstanding 131.06M
Float 132.23M
Shares short 13.69M
% Held by insiders 0.01%
% Held by institutions 1.05%
Average volume (10 days) 837.33K
Average volume (90 days) 1.53M
Price summary
52-Week low 29.08
52-Week high 65
Beta 1.39
50-Day moving average 51.42
200-Day moving average 54.82
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.28%
Return on equity -0.33%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -907.28M
Net income to common (ttm) -766.63M
Diluted EPS (ttm) -6.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.56B
Total cash per share (mrq) 12.45
Total debt (mrq) 117.48M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 7.49%
Book value per share (mrq) 21.48
Cash Flow
Cash flow statement -655.58M
Levered free cash flow (LFCF) -430.85M
